A Study of ZN-c3 in Participants With Solid Tumors

Conditions:   Solid Tumor;   Epithelial Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer;   Triple Negative Breast Cancer;   Small Cell Lung Cancer;   Metastatic Breast Cancer;   Malignant Melanoma;   Non Small Cell Lung Cancer;   Urothelial Carcinoma Interventions:   Drug: ZN-c3;   Drug: Talazoparib;   Drug: Pembrolizumab Sponsors:   K-Group Beta;   IQVIA Biotech Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials